Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
PTSD linked with onset of cognitive impairment in 911 World Trade Center responders

PTSD linked with onset of cognitive impairment in 911 World Trade Center responders

High-fat diets contribute to irregularities in hypothalamus region of the brain

High-fat diets contribute to irregularities in hypothalamus region of the brain

UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

Hearing aid use linked to lower risks of dementia, depression and falls

Hearing aid use linked to lower risks of dementia, depression and falls

Migraines are a significant risk factor for dementia

Migraines are a significant risk factor for dementia

Higher levels of serotonin after a seizure linked to lower incidence of breathing problems

Higher levels of serotonin after a seizure linked to lower incidence of breathing problems

Scientists visualize protein tangles linked with dementia in patients’ brains after single head injury

Scientists visualize protein tangles linked with dementia in patients’ brains after single head injury

Resistance to 'hunger hormone' linked with cognitive impairments and memory loss

Resistance to 'hunger hormone' linked with cognitive impairments and memory loss

New insight and target for Alzheimer’s disease

New insight and target for Alzheimer’s disease

Neurogenesis plays an underappreciated role in the progression of Alzheimer's

Neurogenesis plays an underappreciated role in the progression of Alzheimer's

Researchers find protective factor against Alzheimer’s disease

Researchers find protective factor against Alzheimer’s disease

Potential drug could revolutionize the treatment of neurological conditions

Potential drug could revolutionize the treatment of neurological conditions

AAN publishes new guideline on vaccinations for people with multiple sclerosis

AAN publishes new guideline on vaccinations for people with multiple sclerosis

Married people less likely to experience dementia, finds study

Married people less likely to experience dementia, finds study

Bruker announces world's first 1.2 GHz high-resolution protein NMR data

Bruker announces world's first 1.2 GHz high-resolution protein NMR data

"Australian" genetic mutation provides clues to Alzheimer’s mechanism

"Australian" genetic mutation provides clues to Alzheimer’s mechanism

Caltech researchers determine how memories form and fade

Caltech researchers determine how memories form and fade

Caregivers of people with dementia experience accumulation of sleep loss

Caregivers of people with dementia experience accumulation of sleep loss

Adults carrying Alzheimer's risk gene have harder time accessing recently acquired knowledge

Adults carrying Alzheimer's risk gene have harder time accessing recently acquired knowledge

Addiction clinics market pricey, unproven treatments to desperate patients

Addiction clinics market pricey, unproven treatments to desperate patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.